abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
93796: Ret Sequencing And Deletion/duplication Print View
Result      
Reviewer      
Resource      
Method and Limitation      
Additional Information      
Comments      

PRIMARY
1 Whole Blood EDTA 5 (2) mL   Room Temperature - 8 Day(s)/Refrigerated - 8 Day(s)  
ALTERNATE
  Whole Blood ACD Sol A 5 (2) mL   Room Temperature - 8 Day(s)/Refrigerated - 8 Day(s)  
  Whole Blood ACD Sol B 5 (2) mL   Refrigerated - 8 Day(s)/Room Temperature - 8 Day(s)  

Germline mutations within the RET proto-oncogene cause Multiple endocrine neoplasia type 2 (MEN 2), with a high lifetime risk of medullary thyroid cancer and pheochromocytoma. This test detects pathogenic variants in the RET proto-oncogene.

Specimen stability is crucial. Store and ship room temperature
immediately. Do not freeze. Send report of results for family member
with known mutation.
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
12 days

CPT Codes
81406,81479

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
If Result is positive, cascading reflex to Path Variant, Variant 1, and VUS will be performed as needed.

Transport Temperature: Room temperature Reject Criteria: Gross Hemolysis, Clotted Methodology: Massively Parallel Sequencing Report available: 12 days from completed pre-author.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database